Astria Therapeutics, Inc.: cashflow_financing

Value{"amount": 7480000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2018-01-01 – 2018-03-31
Statuscurrent
EntityAstria Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-18-031966 · Open the official SEC filing →
Retrieved: 2026-08-19T14:22:38.938284+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001454789/cashflow-financing/2018-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/8a0cf384-a4de-423b-a879-ac72b5ebde42

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies